Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART

Clinical Infectious Diseases

Volumn 46, Issue 12, 2008, Pages 1902-1910

  Isgrò, Antonella ^a   Leti, Wilma ^b   De Santis, Wladimiro ^b   Marziali, Marco ^a   Esposito, Antonella ^b   Fimiani, Caterina ^b   Luzi, Giuseppe ^c   Pinti, Marcello ^d   Cossarizza, Andrea ^d   Aiuti, Fernando ^b   Mezzaroma, Ivano ^b,e  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Section of Clinical Pharmacology   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; HEMOGLOBIN; INTERLEUKIN 2; INTERLEUKIN 7; RNA; TUMOR NECROSIS FACTOR ALPHA; FAS ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; BLOOD LEVEL; BONE MARROW; BONE MARROW CELL; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CULTURE; CELL FUNCTION; CLINICAL ARTICLE; CLONOGENESIS; COLONY FORMING CELL; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMOGLOBIN BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; STROMA CELL; T LYMPHOCYTE ACTIVATION; THROMBOCYTE COUNT; VIRUS REPLICATION; AGED; BIOSYNTHESIS; BLOOD; COMPARATIVE STUDY; DRUG EFFECT; HEMATOPOIETIC STEM CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; LYMPHOPOIESIS; MIDDLE AGED; VIROLOGY; VIRUS LOAD;

ADULT; AGED; ANTIGENS, CD95; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BONE MARROW; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FAS LIGAND PROTEIN; FEMALE; HEMATOPOIETIC STEM CELLS; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-2; INTERLEUKIN-7; LYMPHOPOIESIS; MALE; MIDDLE AGED; RNA, VIRAL; STROMAL CELLS; TUMOR NECROSIS FACTOR-ALPHA; VIRAL LOAD;

EID: 46249104669     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/588480     Document Type: Article

References (37)

1. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997; 337:725-33.
2. Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997; 277:112-6.
3. Mezzaroma I, Carlesimo M, Pinter E, et al. Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy. Clin Infect Dis 1999; 29:1423-30.
4. Kaufmann GR, Perrin L, Pantaleo G, et al. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Arch Intern Med 2003; 163:2187-95.
5. Benveniste O, Flahault A, Rollot F, et al. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads. J Infect Dis 2005; 191:1670-9.
6. Marziali M, De Santis W, Carello R, et al. T cell homeostasis alteration in HIV-1 infected subjects with low CD4+ T-cell count despite undetectable virus load during HAART. AIDS 2006; 20:2033-41.
7. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol 2003;4:1191-8.
8. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol 2000; 1:426-32.
9. Tan JT, Dudl E, LeRoy E, Sprent J, Weinberg KI, Surh CD. IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci USA 2001; 98:8732-7.
10. Rethi B, Fluur C, Atlas A, et al. Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients. AIDS 2005; 19:2077-86.
11. Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RM. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 2002; 169:3400-6.
12. Aiuti F, Mezzaroma I. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART. AIDS Rev 2006; 8:88-97.
13. Eggena MP, Barugahare B, Jones N, et al. Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005; 174:4407-14.
14. Moses A, Nelson J, Bagby GC Jr. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 1998; 91:1479-95.
15. De Luca A, Teofili L, Antinori A, et al. Haemopoietic CD34+ progenitor cells are not infected by HIV-1 in vivo but show impaired clonogenesis. Br J Haematol 1993; 85:20-4.
16. Bahner I, Kearns K, Coutinho S, Leonard EH, Kohn DB. Infection of human marrow stroma by human immunodeficiency virus-1 (HIV-1) is both required and sufficient for HIV-1 induced hematopoietic suppression in vitro: demonstration by gene modification of primary human stroma. Blood 1997; 90:1787-98.
17. Kobari L, Giarratana MC, Poloni A, et al. Flt 3 ligand, MGDF, Epo and G-CSF enhance ex vivo expansion of hematopoietic cell compartments in the presence of SCF, IL-3 and IL-6. Bone Marrow Transplant 1998; 21:759-67.
18. Zauli G, Davis BR, Re MC, Visani G, Furlini G, La Placa M. Tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1 induced hematopoietic suppression. Blood 1992; 80:3036-43.
19. Zauli G, Capitani S. HIV-1-related mechanisms of suppression of CD34+ hematopoietic progenitors. Pathobiology 1996; 64:53-8.
20. Kagi D, Seiler P, Pavlovic J, et al. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytophatic viruses. Eur J Immunol 1995; 25:3256-62.
21. Maciejewski J, Selleri C, Anderson S, Young NS. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995; 85:3183-90.
22. Isgrò A, De Vita L, Mezzaroma I, Aiuti A, Aiuti F. Recovery of haematopoietic abnormalities in HIV-1 infected patients treated with HAART. AIDS 1999; 13:2486-8.
23. Isgrò A, Mezzaroma I, Aiuti A, et al. Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2000; 16:1471-9.
24. Giovannetti A, Pierdominici M, Mazzetta, et al. T cell responses to highly active antiretroviral therapy defined by chemokine receptors expression, cytokine production, T cell receptor repertoire, and anti-HIV T lymphocyte activity. Clin Exp Immunol 2001; 124:1-12.
25. Isgrò A, Aiuti A, Mezzaroma I, et al. Improvement of IL-2 production, clonogenic capability and restoration of stromal cell function in HIV-1 patients after HAART. Br J Haematol 2002; 118:864-74.
26. Isgrò A, Aiuti A, Mazzone AM, Ruco L, Aiuti F, Mezzaroma I. HIV type 1 protease inhibitors enhance bone marrow progenitor cell activity in normal subjects and in HIV type 1 infected patients. AIDS Res Hum Retroviruses 2005; 21:51-7.
27. Pinti M, Troiano L, Nasi M, et al. Balanced regulation of mRNA production for Fas and FasL in lymphocytes from centenarians: how the immune system starts its second century. Circulation 2004; 110:3108-14.
28. Zanussi S, Simonelli C, Bortolin MT, et al. Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or with HAART + Il-2. Clin Exp Immunol 1999; 116:486-92.
29. Keller JR, Ruscetti FW, Grzegorzewski KJ. Transforming growth factor-α, tumor necrosis factor-α, and macrophage inflammatory protein-1α are bidirectional regulators of hematopietic cell growth. In: Garland JM, Quesenberry PJ, Hilton DJ eds. Colony-stimulating factors. Molecular and cellular biology. New York: Marcel Dekker, 1997:445-9.
30. Nagafuji K, Shibuya T, Harada M, et al. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 1995; 86:883-9.
31. Sato T, Selleri C, Anderson S, Young NS, Maciejewski JP. Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells. Br J Haematol 1997; 97:356-65.
32. Dybedal I, Bryder D, Fossum A, Rusten LS, Jacobsen SE. Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells. Blood 2001; 98:1782-91.
33. Katlama C, Carcelain G, Duvivier C, et al. Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study - ANRS 082. AIDS 2002; 16:2027-34.
34. Levy Y, Durier C, Krzysiek R, et al. Effects of interleukin-2 therapy combined with highly active antiretroviral therapy on immune restoration in HIV-1 infection: a randomized controlled trial. AIDS 2003; 17:343-51.
35. Durier C, Capitant C, Lascaux AS, et al. Long-term effects of intermittent interleukin-2 therapy in chronic HIV-infected patients (ANRS 048-079 Trials). AIDS 2007; 21:1887-97.
36. Sudo T, Ito M, Ogawa Y, et al. Interleukin 7 production and function in stromal cell-dependent B cell development. J Exp Med 1989; 170:333-8.
37. Isgrò A, Aiuti F, Mezzaroma I, et al. Interleukin 7 production by bone marrow-derived stromal cells in HIV-1-infected patients during highly active antiretroviral therapy. AIDS 2002; 16:2231-2.